Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients

Atherosclerosis

Volumn 177, Issue 1, 2004, Pages 161-166

  Ascer, Elia ^a   Bertolami, Marcelo C ^a   Venturinelli, Margareth L ^a   Buccheri, Valéria ^a   Souza, Juliana ^a   Nicolau, José C ^a   Ramires, José Antônio F ^a   Serrano Jr , Carlos V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atorvastatin; Cytokines; Hypercholesterolaemia; Inflammatory markers; Intercellular adhesion molecule 1

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PYRROLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 5444260617     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.07.003     Document Type: Article

References (32)

1. R.S. Hornung Reducing cholesterol and atherosclerosis Q. J. Med. 95 2002 339 341
2. C.C. Case, and C.M. Ballantyne Statins and inflammatory markers Curr. Atheroscler. Rep. 4 2002 42 47
3. J.A. Ambrose, and E.E. Martinez A new paradigm for plaque stabilization Circulation 105 2002 2000 2004
4. R. Ross Atherosclerosis: an inflammatory disease New Engl. J. Med. 340 1999 115 126
5. O. Wiklund, L. Mattson-Hulten, E. Hurt-Camejo, and J. Oscarsson Effects of simvastatin and atorvastatin on inflammation markers in plasma J. Intern. Med. 251 2002 338 347
6. P. Proost, A. Wuyts, and J. Van Damme The role of chemokines in inflammation Int. J. Clin. Lab. Res. 26 1996 211 223
7. M.P. Bevilacqua, and M.A. Gimbrone Jr. Inducible endothelial functions in inflammation and coagulation Semin. Thromb. Hemost. 13 1987 425 433
8. S.B. Ng, Y.H. Tan, and G.R. Guy Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1 J. Biol. Chem. 269 1994 19021 19027
9. H.G. Rus, R. Vlaicu, and F. Niculescu Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall Atherosclerosis 127 1996 263 271
10. P.C. Heinrich, J.V. Castell, and T. Andus Interleukin-6 the acute phase response Biochem. J. 265 1990 621 636
11. G.K. Hansson Immune mechanisms in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 21 2001 1876 1890
12. J.E. Volanakis Complement activation by C-reactive protein complexes Ann. NY Acad. Sci. 389 1982 235 250
13. M. Torzewski, C. Rist, and R.F. Mortensen C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis Arterioscler. Thromb. Vasc. Biol. 20 2000 2094 2099
14. S.P. Ballou, and G. Lozanski Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein Cytokine 4 1992 361 368
15. P.M. Ridker, N. Rifai, and M. Clearfield The Air Force/Texas Coronary Atherosclerosis Prevention Study. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events New Engl. J. Med. 344 2001 1959 1965
16. The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-23.
17. F. Di Giovine, and G. Duff Interleukin 1: the first interleukin Immunol. Today 11 1990 13 20
18. H. Brailly, F.A. Montero-Julian, and C. Zuber Total interleukin-6 in plasma measured by immunoassay Clin. Chem. 40 1994 116 123
19. A. Corti, G. Fassina, F. Marcucci, E. Barbanti, and G. Cassani Oligomeric Tumor necrosis factor-α slowly converts into inactive forms at bioactive levels Biochem. J. 284 1992 905 910
20. A. Gearing, and W. Newman Circulating adhesion molecules in disease Immunol. Today 14 1993 506 512
21. A.S. Glantz Primer of bio-statistics 3rd ed. 1992 McGraw-Hill New York
22. P.M. Ridker, N. Rifai, M. Pfeffer, F. Sacks, S. Lepage, and E. Braunwald Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction Circulation 101 2000 2149 2153
23. P.M. Ridker, C.H. Hennekens, B. Roitman-Johnson, M.J. Stampfer, and J. Allen Plasma concentration of soluble intercellular adhesion molecule-1 and risks of future myocardial infarction in apparently healthy men Lancet 351 1998 88 92
24. A. Rezaie-Majd, T. Maca, and R. Bucek Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients Arterioscler. Thromb. Vasc. Biol. 22 2002 1194 1199
25. J. Davignon, and R. Laaksonen Low-density lipoprotein-independent effects of statins Curr. Opin. Lipidol. 10 1999 543 559
26. Y. Liu, L.M. Hulten, and O. Wiklund Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production Arterioscler. Thromb. Vasc. Biol. 17 1997 317 323
27. Y. Liu-Wu, E. Hurt-Camejo, and O. Wiklund Lysophosphatidylcholine induces the production of IL-1beta by human monocytes Atherosclerosis 137 1998 351 357
28. A. Tedgui, and Z. Mallat Anti-inflammatory mechanisms in the vascular wall Circ. Res. 88 2001 877 887
29. G.W. Cockerill, T.Y. Huehns, and A. Weerasinghe Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation Circulation 103 2001 108 112
30. R. de Martin, M. Hoeth, R. Hofer-Warbinek, and J.A. Schmid The transcription factor NF-kB and the regulation of vascular cell function Arterioscler. Thromb. Vasc. Biol. 20 2000 E83 E88
31. R.S. Rosenson, and K. Wolfgang High-sensitivity C-reactive protein and cardiovascular risk in patients with coronary heart disease Curr. Opin. Cardiol. 17 2002 325 331
32. T.A. Pearson, G.A. Mensah, and R.W. Alexander Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511